Medical data platform company JNPMEDI, led by CEO Kwunho Jeong, will participate in the 38th Korea International Medical & Hospital Equipment Show (KiMES 2023) from March 23rd to 26th at COEX in Seoul.
Founded in 2020, JNPMEDI seeks to innovate the clinical trial industry through digital technology. The company has developed the 'Maven Clinical Cloud' solution, a clinical trial data management platform that offers innovative digital solutions for various medical fields, including pharmaceuticals, biotech, medical devices, and digital therapeutics. JNPMEDI is recognized as a new leader in advancing the decentralized clinical trials (DCT) market.
At KiMES 2023, JNPMEDI will have an independent booth to engage with clinical trial professionals and showcase the 'Maven Clinical Cloud' solution, which is essential for DCT. They will also present services that enable patient-centric remote clinical trials without the need for visits to medical institutions, featuring tools like electronic consent (eConsent), identity verification, and electronic clinical outcome assessment (eCOA). The 'Maven Clinical Cloud' solution, a core service of JNPMEDI, is distinguished by its proactive adoption of DCT technology, keeping pace with the trend towards non-contact methods.
Recently, JNPMEDI expanded its business development team by recruiting industry experts. The company plans to focus on expanding its domestic and global business scope and enhancing its brand image, aiming to accelerate revenue growth through various partnerships.
KiMES 2023 will showcase new technologies and products in the medical industry, such as smart healthcare, medical robotics, eco-friendly medical waste facilities, advanced hospital facilities, and IT-integrated medical information systems, in line with the fourth industrial revolution.
Medical data platform company JNPMEDI, led by CEO Kwunho Jeong, will participate in the 38th Korea International Medical & Hospital Equipment Show (KiMES 2023) from March 23rd to 26th at COEX in Seoul.
Founded in 2020, JNPMEDI seeks to innovate the clinical trial industry through digital technology. The company has developed the 'Maven Clinical Cloud' solution, a clinical trial data management platform that offers innovative digital solutions for various medical fields, including pharmaceuticals, biotech, medical devices, and digital therapeutics. JNPMEDI is recognized as a new leader in advancing the decentralized clinical trials (DCT) market.
At KiMES 2023, JNPMEDI will have an independent booth to engage with clinical trial professionals and showcase the 'Maven Clinical Cloud' solution, which is essential for DCT. They will also present services that enable patient-centric remote clinical trials without the need for visits to medical institutions, featuring tools like electronic consent (eConsent), identity verification, and electronic clinical outcome assessment (eCOA). The 'Maven Clinical Cloud' solution, a core service of JNPMEDI, is distinguished by its proactive adoption of DCT technology, keeping pace with the trend towards non-contact methods.
Recently, JNPMEDI expanded its business development team by recruiting industry experts. The company plans to focus on expanding its domestic and global business scope and enhancing its brand image, aiming to accelerate revenue growth through various partnerships.
KiMES 2023 will showcase new technologies and products in the medical industry, such as smart healthcare, medical robotics, eco-friendly medical waste facilities, advanced hospital facilities, and IT-integrated medical information systems, in line with the fourth industrial revolution.